Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells

Fertil Steril. 2009 May;91(5 Suppl):2185-92. doi: 10.1016/j.fertnstert.2008.04.052. Epub 2008 Aug 5.

Abstract

Objective: To determine whether high levels of interleukin (IL)-10 can attenuate the production of tumor necrosis factor (TNF)-alpha-induced proinflammatory cytokines in endometriotic stromal cells.

Design: Prospective study.

Setting: Department of Ob/Gyn, Tottori University, Japan.

Patient(s): Thirty-five patients with ovarian endometrioma and ten patients with uterine myoma.

Intervention(s): Endometriotic stromal cells were obtained from chocolate cyst linings of ovaries. Endometrial stromal cells obtained from patient with uterine myoma.

Main outcome measure(s): Expression of IL-10 gene in endometriotic or endometrial stromal cells was determined by real-time reverse-transcriptase polymerase chain reaction (RT-PCR). We performed immunohistochemical staining to find the presence of IL-10 and IL-10 receptors 1 and 2. We examined the effects of TNF-alpha and IL-10 on the expression of IL-6 or IL-8 by real-time RT-PCR and ELISA. We examined the activation of intracellular signal transduction molecules in endometriotic stromal cells by Western blotting.

Result(s): Addition of IL-10 suppressed the expressions of IL-6 induced by TNF-alpha and IL-10 induced the phosphorylation of STAT3 in endometriotic stromal cells. TNF-alpha induced the expression of phosphorylated ERK1/2, JNK1/2, and I kappaB. Adding IL-10 suppressed the phosphorylation of these signal molecules.

Conclusion(s): Interleukin-10 attenuates TNF-alpha-induced IL-6 synthesis via NF-kappaB and MAPK pathways in endometriotic cells.. Interleukin-10 may play a significant role in the pathogenesis of endometriosis.

MeSH terms

  • DNA Primers
  • Endometriosis / drug therapy
  • Endometriosis / pathology*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interleukin-10 / genetics*
  • Interleukin-10 / metabolism
  • Interleukin-10 / therapeutic use
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / genetics
  • Leiomyoma / pathology*
  • NF-kappa B / genetics
  • Ovarian Neoplasms / pathology*
  • RNA, Messenger / genetics
  • Receptors, Interleukin-10 / drug effects
  • Receptors, Interleukin-10 / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stromal Cells / drug effects
  • Stromal Cells / pathology*
  • Stromal Cells / physiology
  • Transcription Factors / genetics
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / physiology*
  • Uterine Neoplasms / pathology

Substances

  • DNA Primers
  • Interleukin-6
  • NF-kappa B
  • RNA, Messenger
  • Receptors, Interleukin-10
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • Interleukin-10